The Pacific Movement Disorders Center team is excited to announce that we are one of the sites participating in the PROSPECT trial from Cala Health, a three month study for people who have mild to severe essential tremor. The trial is open for patient enrollment.
Find out about the latest clinical trials at Pacific Neuroscience Institute for brain tumor, stroke, movement disorders, and other neurological areas. Call our center at 310-829-8265 to enroll.
Nativis Announces Publication of Study in Patients with Recurrent Glioblastoma (rGBM). Data suggest the Nativis Voyager® device is safe for treatment of rGBM.
Dr. Sarah McEwen’s determination to make a difference bridges the gap between academic research and the underserved populations in the community. Her research and clinical work implement physical and cognitive interventions simultaneously during the earliest phases of illness with the possibility of preventing cognitive decline. Read more.
Find out about the latest clinical trials at Pacific Neuroscience Institute for brain tumor, stroke and other neurological areas. Call our center at 310-829-8265 to enroll.
The EndBrainCancer Initiative Receives CITI Certification Becoming the First Brain Tumor Patient Advocacy Organization Listed as a Nationally-Recognized Recruiting Site.
The Wizard201G clinical trial from Boston Biomedical Inc. is a vaccine treatment for patients with recurrent or progressive GBM following initial treatment. Pacific Neuroscience Institute is a site for this phase 2 study which is currently recruiting. Contact us for eligibility criteria at 310-582-7460.
Check out Pacific Neuroscience Institute’s advanced clinical trials line up for May 2018. PNI is very excited to announce a new clinical trial for the assessment and treatment of patients with newly diagnosed glioblastoma. Find out how Dr. Santosh Kesari’s protocol tackles brain cancer treatment in a whole new way.
Dr. Santosh Kesari’s new clinical trial approaches glioblastoma treatment in a whole new way. By giving immunotherapy first rather than radiation and chemotherapy, the patient’s immune system remains uncompromised which could result in better responses and lead to better patient outcomes.
Pacific Neuroscience Institute is pleased to announce a new clinical trial for traumatic brain injury patients who have been suffering from chronic motor deficits for more than a year. This study is currently enrolling patients. Clinical trials help bring much needed treatments and therapies to market. Find out more about PNI trials for treatment of primary brain tumors such as glioblastoma, metastatic brain tumors that arise from cancers affecting the breast, lung or skin, quality and outcomes research and other neurological studies.
